Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

V-TADA SUPER-20

Description: V-Tada Super-20 is a medication manufactured by Vipro Lifescience, containing the active substance tadalafil. It is a phosphodiesterase type 5 (PDE5) inhibitor used primarily in the treatment of erectile dysfunction (ED) in adult men. V-Tada Super-20 is formulated to provide a potent dosage of tadalafil, allowing for enhanced efficacy in managing ED.

Active Substance: The active substance in V-Tada Super-20 is tadalafil. Tadalafil works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which regulates blood flow in the penis. By inhibiting PDE5, tadalafil enhances the effects of nitric oxide, leading to increased blood flow into the penile tissues during sexual stimulation, thereby facilitating and maintaining an erection.

Manufacturer: V-Tada Super-20 is manufactured by Vipro Lifescience, a reputable pharmaceutical company known for its high-quality generic medications. Vipro Lifescience adheres to strict quality control measures and regulatory standards to ensure the safety, efficacy, and consistency of its products.

Form: This medication is available in the form of tablets, with each tablet containing 20 mg of tadalafil. The tablets are typically packaged in blister packs containing 10 tablets.

Uses: V-Tada Super-20 is primarily indicated for the treatment of erectile dysfunction (ED) in adult men. It is used to improve erectile function and enhance sexual performance by increasing blood flow to the penis during sexual stimulation. This medication is not intended for use in women or children.

Storage Conditions: V-Tada Super-20 should be stored at room temperature, away from moisture, heat, and direct light. It should be kept out of reach of children and pets. Unused or expired medication should be properly disposed of according to local regulations.

Mechanism of Action: Tadalafil, the active ingredient in V-Tada Super-20, works by selectively inhibiting the enzyme phosphodiesterase type 5 (PDE5) in the corpus cavernosum of the penis. This inhibition leads to increased levels of cyclic guanosine monophosphate (cGMP), which promotes relaxation of smooth muscle cells and vasodilation, allowing for increased blood flow into the penis and the attainment and maintenance of an erection.

How to Use: V-Tada Super-20 should be taken orally with a full glass of water, approximately 30 minutes to 1 hour before anticipated sexual activity. The dosage may vary depending on individual response and tolerance, but the recommended starting dose is usually 10 mg once daily, with or without food. The maximum recommended dose is 20 mg once daily. It is important to avoid consuming alcohol or large meals high in fat before taking V-Tada Super-20, as these may reduce the effectiveness of the medication.

Precautions: Before using V-Tada Super-20, patients should inform their healthcare provider about any medical conditions they have, especially those related to heart health, blood pressure, liver or kidney function, and any medications they are taking, particularly nitrates or alpha-blockers.

Drug Interactions: V-Tada Super-20 may interact with certain medications, particularly those containing nitrates or alpha-blockers, as well as other PDE5 inhibitors. Patients should inform their healthcare provider about all medications they are taking before starting treatment with V-Tada Super-20 to avoid potential drug interactions.

Contraindications: This medication is contraindicated in patients with a known hypersensitivity to tadalafil or any of its components, as well as those who are taking nitrates or nitric oxide donors for angina or pulmonary arterial hypertension. It should not be used in women or children.

Overdose: In case of overdose, patients should seek immediate medical attention. Symptoms of overdose may include severe headache, dizziness, nausea, fainting, and priapism (prolonged and painful erection).

Adverse Reactions: Common adverse reactions associated with V-Tada Super-20 include headache, flushing, dyspepsia, nasal congestion, dizziness, and visual disturbances. Patients should report any persistent or severe side effects to their healthcare provider.